rts logo

Positives for AbCellera Biologics Inc (ABCL) as stock gains in recent trading

AbCellera Biologics Inc (NASDAQ: ABCL) is -28.33% lower on its value in year-to-date trading and has touched a low of $1.89 and a high of $4.34 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ABCL stock was last observed hovering at around $2.06 in the last trading session, with the day’s gains setting it 0.04%.

Currently trading at $2.10, the stock is -10.62% and -9.65% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 17.01 million and changing 1.94% at the moment leaves the stock -22.55% off its SMA200. ABCL registered -46.84% loss for a year compared to 6-month loss of -22.79%.

The stock witnessed a -12.50% gain in the last 1 month and extending the period to 3 months gives it a -28.81%, and is 3.45% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.34% over the week and 6.32% over the month.

AbCellera Biologics Inc (ABCL) has around 596 employees, a market worth around $626.82M and $23.12M in sales. Profit margin for the company is -726.23%. Distance from 52-week low is 11.08% and -51.61% from its 52-week high. The company has generated returns on investments over the last 12 months (-15.45%).

The EPS is expected to shrink by -13.65% this year.

AbCellera Biologics Inc (ABCL) Top Institutional Holders

The shares outstanding are 298.36M, and float is at 223.95M with Short Float at 10.27%.

The top institutional shareholder in the company is BAKER BROS. ADVISORS LP with over 27.53 million shares valued at $81.48 million. The investor’s holdings represent 9.3556% of the ABCL Shares outstanding. As of 2024-06-30, the second largest holder is BAILLIE GIFFORD & CO with 21.91 million shares valued at $64.86 million to account for 7.4472 of the shares outstanding. The other top investors are VOYA INVESTMENT MANAGEMENT LLC which holds 10.62 million shares representing 3.611% and valued at over $31.45 million, while CAPITAL WORLD INVESTORS holds 1.8078 of the shares totaling 5.32 million with a market value of $15.74 million.

AbCellera Biologics Inc (ABCL) Insider Activity

#####

Related Posts